2m 2m 2m 2m 2m 2m 2m
Merit Med Sys (MMSI)
NASDAQ
$67.24+$0.74 (+1.11%)
Price as of Jun 23, 2026 6:21 PM EDT- $4.0BMarket Cap
- -27.97%1-Year Change
- Medical Instruments & SuppliesIndustry
Merit Med Sys (MMSI)
$67.24+$0.74 (+1.11%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.5B +11.75% | 1.4B +7.89% | 1.3B +9.24% | 1.2B +7.09% | |
Cost of Revenue | 777.6M +9.04% | 713.2M +5.89% | 673.5M +6.59% | 631.9M +7.20% | |
Gross Profit | 738.3M +14.76% | 643.3M +10.18% | 583.9M +12.48% | 519.1M +6.96% | |
Sales and Marketing Expense | 455.2M +13.88% | 399.7M +6.97% | 373.7M +9.09% | 342.5M +2.04% | |
Research and Development Expense | -97.4M +11.30% | -87.5M +5.73% | -82.7M +9.56% | -75.5M +5.98% | |
Depreciation and Amortization Expense | 123.2M +19.92% | 102.7M +14.14% | 90.0M +10.00% | 81.8M -2.69% | |
Total Operating Expenses | 553.5M +13.52% | 487.6M +6.03% | 459.9M +6.58% | 431.5M +1.68% | |
Operating Profit | 184.7M +18.64% | 155.7M +25.62% | 123.9M +41.55% | 87.6M +43.74% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -15.5M +144.69% | -6.3M +20.49% | |
Interest Income and Expense and Net | 0 N/A | 0 +100.00% | -15.5M +144.69% | -6.3M +20.49% | |
Total Nonoperating Income and Expense | -13.8M +141.81% | -5.7M -51.92% | -11.9M +140.27% | -4.9M -29.50% | |
Income before Taxes | 170.9M +13.96% | 150.0M +33.82% | 112.1M +35.65% | 82.6M +53.25% | |
Income Taxes | 42.4M +43.23% | 29.6M +67.64% | 17.7M +117.90% | 8.1M +48.51% | |
Extraordinary Items | 270,000 0.00% | 270,000 0.00% | 270,000 -87.83% | 2.2M -48.19% | |
Net Income | 128.5M +6.76% | 120.4M +27.48% | 94.4M +26.70% | 74.5M +53.79% | |
Net Income from Continuing Operations Applicable to Common | 170.9M +13.96% | 150.0M +33.82% | 112.1M +35.65% | 82.6M +53.25% | |
Basic EPS and Net Income | 2.17 +4.83% | 2.07 +26.22% | 1.64 +25.19% | 1.31 +52.33% | |
Diluted EPS and Net Income | 2.13 +4.93% | 2.03 +25.31% | 1.62 +25.58% | 1.29 +53.57% | |
Basic Weighted Average Shares | 59.2M +1.61% | 58.2M +1.09% | 57.6M +1.39% | 56.8M +1.18% | |
Diluted Weighted Average Shares | 60.5M +1.84% | 59.4M +1.73% | 58.4M +1.19% | 57.7M +0.54% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 446.4M +18.50% | 376.7M -35.83% | 587.0M +905.06% | 58.4M -13.79% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 446.4M +18.50% | 376.7M -35.83% | 587.0M +905.06% | 58.4M -13.79% | |
Total Current Assets | 1.0B +12.60% | 923.8M -16.66% | 1.1B +109.51% | 529.1M +9.72% | |
Accumulated Depreciation | 376.4M +7.06% | 351.6M +6.86% | 329.0M +8.50% | 303.3M +8.07% | |
Property and Plant and Equipment and Net | 428.4M +10.94% | 386.2M +0.69% | 383.5M +0.14% | 383.0M +3.05% | |
Total Long-Term Assets | 78.2M +19.73% | 65.3M +19.24% | 54.8M +23.54% | 44.4M +7.08% | |
Total Assets | 2.7B +11.05% | 2.4B +4.02% | 2.3B +39.74% | 1.7B +0.95% | |
Income Taxes Payable | 28.5M +599.09% | 4.1M -62.85% | 11.0M -56.95% | 25.5M -25.82% | |
Total Short-Term Debt | N/A N/A | N/A N/A | 11.3M 0.00% | 11.3M +33.33% | |
Total Current Liabilities | 239.8M +10.80% | 216.4M +6.31% | 203.6M -7.74% | 220.6M -6.62% | |
Total Long-Term Debt | 734.0M +0.62% | 729.6M -11.36% | 823.0M +340.68% | 186.8M -20.32% | |
Total Long-Term Liabilities | 10.3M -33.30% | 15.5M +11.72% | 13.8M -6.15% | 14.7M -37.52% | |
Total Liabilities | 1.1B +6.00% | 1.0B -7.48% | 1.1B +116.19% | 519.6M -14.61% | |
Retained Earnings | 824.0M +18.47% | 695.5M +20.92% | 575.2M +19.64% | 480.8M +18.34% | |
Total Stockholders Equity | 1.6B +14.86% | 1.4B +14.76% | 1.2B +5.03% | 1.1B +10.06% | |
Total Shares Outstanding | 59.4M +1.16% | 58.7M +1.53% | 57.9M +0.96% | 57.3M +1.30% | |
Cash Flow | |||||
Cash from Operating Activities | 297.4M +34.68% | 220.8M +52.12% | 145.2M +27.00% | 114.3M -22.37% | |
Capital Expenditures | 81.7M +132.54% | 35.1M +2.48% | 34.3M -23.85% | 45.0M +61.17% | |
Cash from Investing Activities | -247.4M -32.89% | -368.7M +110.24% | -175.3M +205.50% | -57.4M +54.45% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 16.0M +126.66% | -60.0M -110.73% | 559.3M +1,028.09% | -60.3M -38.78% | |
Financials Ratio | |||||
Gross Margin | 48.70% +2.69% | 47.43% +2.13% | 46.44% +2.96% | 45.10% -0.13% | |
Operating Margin | 12.19% +6.17% | 11.48% +16.43% | 9.86% +29.57% | 7.61% +34.22% | |
Return on Assets | 5.03% -0.79% | 5.07% +7.20% | 4.73% +5.20% | 4.50% +53.80% | |
Return on Equity | 8.67% -7.01% | 9.33% +15.88% | 8.05% +17.94% | 6.82% +40.70% | |
Revenue Growth | 11.75% +49.01% | 7.89% -14.69% | 9.24% +30.32% | 7.09% -38.34% | |
Current Ratio | 4.34 +1.63% | 4.27 -21.61% | 5.45 +127.09% | 2.40 +17.50% | |
Cash Ratio | 1.86 +6.95% | 1.74 -39.64% | 2.88 +989.46% | 0.26 -7.67% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | 0.69 +301.21% | 0.17 -25.91% | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | 0.36 +201.51% | 0.12 -19.21% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow